DocDollars

Halozyme Inc

CA · United States · Reporting entity ID 100000010716

Total reported 2019–2025
$8.19M
#553 of 2,960 reporting companies — 0% of all reported industry payments
$481K in general payments across 15,308 records, plus $7.71M in research funding across 2,592 records.

How it breaks down

General payments $480,895
Research funding $7,713,533

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Halozyme Inc reported $8.19M to US doctors and teaching hospitals from 2019 to 2025, ranking #553 of 2,960 reporting companies. 94% of that was research funding and 6% general payments such as consulting, speaking, food and travel. 15,308 general payment records and 2,592 research records were filed.

Common questions about Halozyme Inc

How much has Halozyme Inc paid US doctors?

Halozyme Inc reported $8,194,429 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $480,895 in general payments, $7,713,533 in research funding.

How does Halozyme Inc rank among drug and device companies?

It ranks #553 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Halozyme Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.